ASCEND BY NTHRYS
Research Abroad Products

Exomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 85–96 of 200 project topics
Population Exome Cohort Analysis and Stratification Platform
Enterprise analytics tool designed for biobanks and research institutions to perform large-scale exome association studies, ancestry analysis, and disease burden stratification across diverse populations. Monetizes through per-sample analysis fees, data access licensing, and custom research consulting engagements with pharmaceutical and genomics companies.
Exomics Investment Analytics Tools Click to view more details →
Cancer Exome Somatic Mutation Calling and Tumor Profiling Suite
Specialized commercial software stack for detecting somatic variants, copy number alterations, and tumor mutational burden from cancer exome sequencing with tumor-normal pair analysis. Delivers revenue through oncology laboratory partnerships, cancer center institutional licensing, and integration into clinical tumor profiling workflows.
Exomics Investment Analytics Tools Click to view more details →
Exome Data Integration and Secondary Finding Detection System
HIPAA-compliant SaaS platform that automatically screens exome data against ACMG secondary finding gene lists, regulatory databases, and institutional variant repositories with real-time alerting. Generates B2B revenue through clinical laboratory subscriptions and reduces liability while improving patient care outcomes for incidental findings.
Exomics Investment Analytics Tools Click to view more details →
Structural Variant Detection and CNV Analysis from Exome Data
Specialized tool that detects copy number variations, indels, and balanced rearrangements from exome capture and sequencing data using depth-of-coverage and breakpoint analysis algorithms. Creates commercial value for diagnostic laboratories by expanding the clinical utility of existing exome assays and identifying 15-20% additional pathogenic variants.
Exomics Investment Analytics Tools Click to view more details →
Exome Variant Classification and Evidence Aggregation Marketplace
Cloud-based platform aggregating variant pathogenicity evidence from literature, functional databases, population frequencies, and expert crowdsourcing with automated ACMG classification pipelines. Monetizes through subscription access, institutional data licensing, and premium interpretation services while supporting clinical labs'' variant classification workflows.
Exomics Investment Analytics Tools Click to view more details →
Genetic Counseling Decision Support and Patient Risk Stratification Tool
Interactive SaaS platform that integrates exome results with family history, clinical phenotypes, and polygenic risk scores to guide genetic counseling workflows and patient risk communication strategies. Generates revenue through genetic testing laboratory partnerships, telehealth platform integrations, and per-patient engagement fees while improving patient outcomes and satisfaction.
Exomics Investment Analytics Tools Click to view more details →
Real-time Tumor Mutation Profiling SaaS Platform
A cloud-based SaaS platform that analyzes whole exome sequencing data to identify actionable tumor mutations within 48 hours for clinical decision-making. Enables oncologists to prescribe precision therapies faster, reducing time-to-treatment and capturing premium pricing for rapid turnaround diagnostics.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
AI-Powered Cancer Driver Gene Discovery Engine
A machine learning-based diagnostic tool that predicts oncogenic driver mutations and distinguishes pathogenic variants from benign polymorphisms in cancer exomes. Creates recurring revenue through licensing to clinical labs and hospital networks seeking to reduce manual variant interpretation costs.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
Multi-Cancer Exome Panel Customization Marketplace
A configurable platform allowing labs to design and deploy custom exome panels optimized for specific cancer types with pre-validated gene panels and interpretation guidelines. Generates B2B SaaS revenue through subscription licensing, panel design services, and per-sample analysis fees.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
Pharmacogenomic Interaction Prediction for Cancer Treatment
A commercial diagnostic service integrating exome sequencing with pharmacogenomic databases to predict drug-gene interactions and optimal chemotherapy regimens. Monetizes through partnership agreements with pharmaceutical companies and direct clinical lab licensing.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
Liquid Biopsy Exome Data Integration Platform
An enterprise platform that combines circulating tumor DNA analysis with traditional exome sequencing to enable non-invasive cancer monitoring and early recurrence detection. Delivers revenue through clinical laboratory partnerships and high-volume diagnostic testing services.
Cancer Exomics Diagnostics Platform Dev Click to view more details →
Genetic Risk Stratification Engine for Cancer Screening
A B2B diagnostic tool leveraging germline exome analysis to identify cancer susceptibility genes (BRCA1/2, Lynch syndrome markers) and stratify population screening risk tiers. Scales revenue through healthcare system contracts and insurance company partnerships for preventive medicine programs.
Cancer Exomics Diagnostics Platform Dev Click to view more details →